Skip to content

Effect of the regular intake of a beverage enriched with powdered oyster mushrooms on lipid status and cholesterol metabolism in adults with moderately elevated LDL cholesterol levels

Effect of the regular intake of a beverage enriched with powdered oyster mushrooms on lipid status and cholesterol metabolism in adults with moderately elevated LDL cholesterol levels

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00033943
Enrollment
50
Registered
2024-03-21
Start date
2024-07-03
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E78

Interventions

Group 1: 8.4 g powdered oyster mushroom per day in the form of a flavored drink powder for four weeks Group 2: mushroom-free flavored drink powder (control) for four weeks

Sponsors

Universität Bonn
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Moderately elevated LDL cholesterol level: 116 - 190 mg/dL, non-smoker for at least 3 months, written informed consent

Exclusion criteria

Exclusion criteria: Allergies or intolerances against mushrooms or any other food ingredients used in the study, diseases of the liver, gall bladder and/or diabetes and other diseases that may influence the target parameters, pacemaker, intake of lipid-lowering drugs and other medications that may have an influence on the target parameters, (planned) pregnancy, lactation, planned changes in lifestyle, regular intake of supplements that contain ß-glucans or soluble fibers, vegan diet, regular intake of phytosterol-enriched margarine, drug abuse, limited legal capability, participating in another clinical trial.

Design outcomes

Primary

MeasureTime frame
Analysis of LDL cholesterol levels (fasting state) before and after intervention

Secondary

MeasureTime frame
Analysis of other markers of lipid status, sterol metabolism and of the adaptive immune system (fasting state) before and after intervention

Countries

Germany

Contacts

Public ContactSabine Ellinger

Universität Bonn

ellinger@uni-bonn.de+492287362021

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026